At the top of the price band, Corona Remedies is expected to command a post-listing market capitalisation of ₹6,495 crore. Previous Post Maruti Suzuki plans 1 lakh EV charging stations across India by 2030 Next Post Reliance Industries shares are a 'top pick' for Citi in the Indian oil & gas space; Check target Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment